Sources

7 Total Sources

Novo Nordisk CEO Eyes 2 New Uses for Obesity Drugs in Longevity, Aesthetics

Left50%
Right50%
Bloomberg4h ago
Novo Nordisk CEO Mike Doustdar Eyes Longevity, Aesthetics for Obesity Drugs
AD HOC NEWS1d ago
Novo Nordisk Maps Out a Future Beyond Weight Loss, but Investors Are Counting the Days to 2027
finance.biggo.com4h ago
Novo Nordisk Eyes Longevity and Aesthetics as Wegovy Pill Captures 80% New Users — BigGo Finance
X4h ago
NVO CEO Mike Doustdar is looking beyond obesity and diabetes, pointing to potential GLP-1 expansion into longevity and aesthetics, per Bloomberg. Doustdar highlighted research showing semaglutide may protect organs like the heart,
Fortune4h ago
Novo Nordisk CEO looks beyond weight loss to longevity and aesthetics | Fortune
Reddit4h ago
Novo Nordisk CEO looks beyond weight loss to longevity and aesthetics : r/NovoNordisk_Stock
Athletech News11h ago
Novo Nordisk CEO Looks Beyond Weight Loss - Athletech News